Moreover, PAE may be associated with relatively fewer complications, lower cost, and shorter hospitalization.
PAE was less effective regarding improvements in most functional outcomes such as maximum flow rate, prostate volume, and prostate-specific antigen. Pooled estimates suggested no significant difference between TURP and PAE for patient-reported outcomes including International Prostate Symptom Score (2.32 (- 0.44 to 5.09)) and quality of life (0.18 (- 0.41 to 0.77)) at 12 months. Pooled patient-reported scores and functional outcomes were calculated by using a fixed or random-effect model.Įleven articles met our selection criteria and ten independent patient series were included in the final analysis. Meta-analyses were performed using RevMan 5.3, STATA 14, and GraphPad Prism 8. Randomized controlled trials on PAE were collected according to specific inclusion and exclusion criteria. PubMed, Web of Science, and Embase were searched up to May 1, 2020. We also reviewed mean changes from baseline in PAE at selected follow-up points. transurethral resection of the prostate (TURP) in patients affected by benign prostatic hyperplasia (BPH). To investigate the efficacy and safety of prostatic artery embolization (PAE) vs.
0 kommentar(er)
